{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T05:54:12Z","timestamp":1721541252657},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s12022-006-0010-4","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T18:51:14Z","timestamp":1184611874000},"page":"387-398","source":"Crossref","is-referenced-by-count":6,"title":["Differential expression of human telomerase catalytic subunit mRNA by In situ hybridization in pheochromocytomas"],"prefix":"10.1007","volume":"17","author":[{"given":"Zuojie","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Decheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Qu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)81123-X","volume":"92","author":"TM Nakamura","year":"1998","unstructured":"Nakamura TM, Cech TR. Reversing time: origin of telomerase. Cell 92: 587\u2013590, 1998.","journal-title":"Cell"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1200\/JCO.2000.18.13.2626","volume":"18","author":"M Meyerson","year":"2000","unstructured":"Meyerson M. Role of relomerase in normal and cancer cells. J Clin Oncol 18: 2626\u20132634, 2000.","journal-title":"J Clin Oncol"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011\u20132015, 1994.","journal-title":"Science"},{"issue":"4","key":"10_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1572-0241.2002.05623.x","volume":"97","author":"SJ Tang","year":"2002","unstructured":"Tang SJ, Dumot JA, Wang L, et al. Telomerase activity in pancreatic endocrine tumors. Am J Gastroenterol 97(4):1022\u20131030, 2002.","journal-title":"Am J Gastroenterol"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1158\/1078-0432.CCR-03-0389","volume":"10","author":"CB Umbricht","year":"2004","unstructured":"Umbricht CB, Conrad GT, Clark DP, et al. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res 10:5762\u20135768, 2004.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0960-0760(01)00101-7","volume":"78","author":"C Orlando","year":"2001","unstructured":"Orlando C, Gelmini S. Telomerase in endocrine and endocrine-dependent tumors. J Steroid Biochem Mol Biol 78(3):201\u2013214, 2001.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jcp.52.8.555","volume":"52","author":"RJ Michalides","year":"1999","unstructured":"Michalides RJ. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol 52:555\u2013568, 1999.","journal-title":"J Clin Pathol"},{"key":"10_CR8","first-page":"4073","volume":"6","author":"F Hommura","year":"2000","unstructured":"Hommura F, Dosaka-Akita H, Mishina T, et al. Prognostic significance of p27KIP1 protein and Ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 6:4073\u20134081, 2000.","journal-title":"Clin Cancer Res"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-03-0037","volume":"10","author":"U Manne","year":"2004","unstructured":"Manne U, Jhala NC, Jones J, et al. Prognostic significance of p27kip-1 expression in colorectal adenocarcinomas is associated with tumor stage. Clin Cancer Res 10:1743\u20131752, 2004.","journal-title":"Clin Cancer Res"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.4049\/jimmunol.165.8.4346","volume":"165","author":"N Schrantz","year":"2000","unstructured":"Schrantz N, Beney GE, Auffredou MT, et al. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation. J Immunol 165:4346\u20134352, 2000.","journal-title":"J Immunol"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)62295-X","volume":"166","author":"ML Motti","year":"2005","unstructured":"Motti ML, Califano D, Troncone G, et al. Complex regulation of the cyclin-dependent kinase inhbitor p27kipl in thyroid cancer cells by the PI3K\/AKT pathway: regulation of p27kipl expression and localization. Am J Pathol 166:737\u2013749, 2005.","journal-title":"Am J Pathol"},{"key":"10_CR12","first-page":"401","volume":"150","author":"RV Lloyd","year":"1997","unstructured":"Lloyd RV, Jin L, Qian X, et al. Aberrant p27kipl expression in endocrine and other tumors. Am J Pathol 150:401\u2013407, 1997.","journal-title":"Am J Pathol"},{"issue":"4","key":"10_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/01926230290105668","volume":"30","author":"V Pace","year":"2002","unstructured":"Pace V, Pharmates E, Germann PG. Pheochromocytomas and ganglioneuromas in the aging rats: morphological and immunohistochemical characterization. Toxicol Pathol 30(4):492\u2013500, 2002.","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1507\/endocrj.51.47","volume":"51","author":"K Isobe","year":"2004","unstructured":"Isobe K, Yashiro T, Omura S, et al. Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues. Endocr J 51(1):47\u201352, 2004.","journal-title":"Endocr J"},{"issue":"3","key":"10_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.MP.0000056982.07160.E3","volume":"16","author":"EE Elder","year":"2003","unstructured":"Elder EE, Xu D, Hoog A, et al. KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol 16(3):246\u2013255, 2003.","journal-title":"Mod Pathol"},{"issue":"5","key":"10_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LD Thompson","year":"2002","unstructured":"Thompson LD. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26(5):551\u2013566, 2002.","journal-title":"Am J Surg Pathol"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/0046-8177(90)90155-X","volume":"21","author":"RI Linnoila","year":"1990","unstructured":"Linnoila RI, Keiser HR, Steinberg SM, et al. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21:1168\u20131180, 1990.","journal-title":"Hum Pathol"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<175::AID-PATH615>3.0.CO;2-Z","volume":"191","author":"E van der Harst","year":"2000","unstructured":"van der Harst E, Bruining HA, Jaap Bonjer H, et al. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? J Pathol 191:175\u2013180, 2000.","journal-title":"J Pathol"},{"issue":"1","key":"10_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/EP:16:1:023","volume":"16","author":"N Kimura","year":"2005","unstructured":"Kimura N, Watanabe T, Noshiro T, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extradrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16(1):23\u201332, 2005.","journal-title":"Endocr Pathol"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1126\/science.277.5328.955","volume":"277","author":"TM Nakamura","year":"1997","unstructured":"Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955\u2013959, 1997.","journal-title":"Science"},{"issue":"1","key":"10_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF03032405","volume":"11","author":"T Hadar","year":"2005","unstructured":"Hadar T, Shvero J, Yaniv E, et al. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol. Oncol Res. 11(1):45\u201349, 2005.","journal-title":"Pathol. Oncol Res."},{"issue":"9","key":"10_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jcp.2004.024158","volume":"58","author":"S Bravaccini","year":"2005","unstructured":"Bravaccini S, Sanchin MA, Amadori A, et al. Potential of telomerase expression and activity in cervical specimens as a diagnostic tool. J Clin Pathol 58(9):911\u2013914, 2005.","journal-title":"J Clin Pathol"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2407-5-98","volume":"5","author":"N Culhaci","year":"2005","unstructured":"Culhaci N, Sagol O, Karademir S, et al. Expression of transforming growth factor beta-1 and p27Kipl in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer 5:98, 2005.","journal-title":"BMC Cancer"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm0297-227","volume":"3","author":"C Catzavelos","year":"1997","unstructured":"Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of the cell-cycle inhibitor p27Kipl protein: prognostic implications in primary breast cancer. Nat Med 3:227\u2013230, 1997.","journal-title":"Nat Med"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nm0297-222","volume":"3","author":"PL Porter","year":"1997","unstructured":"Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27Kipl and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222\u2013225, 1997.","journal-title":"Nat Med"},{"issue":"7","key":"10_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/carcin\/bgg085","volume":"24","author":"I Horikawa","year":"2003","unstructured":"Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24(7):1167\u20131176, 2003.","journal-title":"Carcinogenesis"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nm0395-249","volume":"1","author":"E Hiyama","year":"1995","unstructured":"Hiyama E, Hiyama K, Yokoyama T, et al. Correlating relomerase activity levels with human neuroblastoma outcomes. Nat Med 1:249\u2013255, 1995.","journal-title":"Nat Med"},{"issue":"9","key":"10_CR28","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1210\/jc.2002-021299","volume":"88","author":"C Boltze","year":"2003","unstructured":"Boltze C, Mundschenk J, Unger N, et al. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. J Clin Endocrinol Metabol 88(9):4280\u20134286, 2003.","journal-title":"J Clin Endocrinol Metabol"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<176::AID-CNCR22>3.0.CO;2-Z","volume":"82","author":"Y Kubota","year":"1998","unstructured":"Kubota Y, Nakada T, Sasagawa I, et al. Elevated levels of telomerase activity in malignant pheochromocytoma, Cancer 82:176\u2013179, 1998.","journal-title":"Cancer"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-0029-1212111","volume":"107","author":"CM Bamberger","year":"1999","unstructured":"Bamberger CM, Else T, Bamberger AM, et al. Telomerase activity in benign and malignant adrenal tumors. Exp Clin Endocrinol Diabetes 107:272\u2013275, 1999.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/1097-0142(19900301)65:5<1180::AID-CNCR2820650525>3.0.CO;2-7","volume":"65","author":"JJ Isola","year":"1990","unstructured":"Isola JJ, Helin HJ, Helle MJ, et al. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis and mitotic count. Cancer 65:1180\u20131184, 1990.","journal-title":"Cancer"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-006-0010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-006-0010-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-006-0010-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-006-0010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T19:28:53Z","timestamp":1652642933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-006-0010-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s12022-006-0010-4","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}